Robert A. Copeland is President & CSO at Epizyme, Inc. (EPZM). They have made 6 open-market trades across 1 company since 2013, most recently 2017-06-06.
CIK 0001571498
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EPZM | 31,538 | $46K |
Shares reported on the most recent Form 4, priced at the 2017-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPZM | SELL · 10b5-1 | 2017-06-06 | 2017-06-07 | $13.45 | $34K | +11.4% | +24.1% | +46.4% |
| EPZM | SELL | 2017-05-02 | 2017-05-03 | $17.44 | $87K | -5.8% | -15.2% | -29.8% |
| EPZM | SELL · 10b5-1 | 2017-04-04 | 2017-04-05 | $16.36 | $41K | -3.9% | +5.2% | +0.6% |
| EPZM | SELL | 2016-08-01 | 2016-08-03 | $10.37 | $83K | -13.9% | -29.3% | -10.2% |
| EPZM | SELL | 2016-07-05 | 2016-07-07 | $10.03 | $80K | -2.1% | -8.8% | -4.0% |
| EPZM | SELL | 2016-01-04 | 2016-01-04 | $15.58 | $130K | -31.4% | -42.5% | -19.8% |
| EPZM | SELL | 2016-01-04 | 2016-01-04 | $15.58 | $61K | -31.4% | -42.5% | -19.8% |
| EPZM | SELL · 10b5-1 | 2015-12-07 | 2015-12-08 | $13.82 | $58K | -37.3% | -29.3% | -34.5% |
| EPZM | SELL · 10b5-1 | 2015-11-09 | 2015-11-10 | $16.26 | $68K | -37.3% | -2.4% | -42.7% |
| EPZM | SELL · 10b5-1 | 2015-10-05 | 2015-10-05 | $14.43 | $60K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2015-09-08 | 2015-09-10 | $19.58 | $82K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2015-08-03 | 2015-08-05 | $22.19 | $186K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2015-07-06 | 2015-07-08 | $22.86 | $191K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-11-17 | 2014-11-19 | $22.68 | $454K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-11-03 | 2014-11-04 | $25.47 | $509K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-10-07 | 2014-10-09 | $26.90 | $538K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-09-22 | 2014-09-24 | $25.55 | $511K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-08-18 | 2014-08-19 | $36.07 | $391K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-08-04 | 2014-08-05 | $29.42 | $588K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-06-23 | 2014-06-25 | $28.42 | $568K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-06-16 | 2014-06-18 | $26.38 | $660K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-06-02 | 2014-06-04 | $22.29 | $856K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-05-19 | 2014-05-21 | $22.28 | $111K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-05-05 | 2014-05-05 | $21.29 | $213K | -37.3% | -2.4% | -2.4% |
| EPZM | SELL · 10b5-1 | 2014-04-28 | 2014-04-30 | $20.73 | $286K | -37.3% | -2.4% | -2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.